🇺🇸 FDA
Pipeline program

10mg DS-8500a tablet

DS8500-A-J201

Phase 2 small_molecule completed

Quick answer

10mg DS-8500a tablet for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).

Program details

Company
Daiichi Sankyo
Indication
Type 2 Diabetes Mellitus
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials